Chandra Bhagat Pharma Ltd IPO

chandrabaghat logo

Chandra Bhagat Pharma Ltd IPO is a BSE SME IPO, which is open for all investors from 31st January 2020, Friday to 6th February 2020, Thursday. Promoters are offering 2,000,000 equity shares to public through this issue which is worth of Rs 10.2 Crores. For other IPO details on Chandra Bhagat Pharma Ltd IPO, scroll below

IPO Details

Grey Market Premium of Chandra Bhagat Pharma Ltd IPO

GMP of Chandra Bhagat Pharma Ltd IPO is currently Not Available. Grey Market Premium will be updated once it’s available

Allotment Status of Chandra Bhagat Pharma Ltd IPO

Expected Listing Gains of Chandra Bhagat Pharma Ltd IPO

Error requesting data: cURL error 28: Operation timed out after 5000 milliseconds with 0 bytes received

Company Background

Chandra Bhagat Pharma Ltd is a Mumbai based entity engaged in ethical marketing of pharma products, with an annual revenue of Rupees 33.445 crores.

  • Company has a FDA approval for contract manufacturing of pharma products. Company also takes trademarks and approvals as and when required
  • Company has 58 employees on its payroll to carry out operations
  • Company is leveraging 208 trademarks out of which 102 are in company’s name
  • Company has taken 9 different insurance policies to tackle future uncertainties

Date of Incorporation

Chandra Bhagat Pharma Ltd was incorporated as Chandra Bhagat Pharma Private Limited on 10th March 2003. Company was finally converted into a public limited company on 20th March 2019 with a Corporate Identification Number, U24230MH2003PLC139534

Promoters of Chandra Bhagat Pharma Ltd

Mr. Hemant Chandravadan Bhagat and Mr. Pranav Hemant Bhagat are the promoters of the company

Product & Services Offered

Chandra Bhagat Pharma Ltd offers following products & services to its clients:-

  • Company offers its marketing services for critical care range of products
  • Company deals in pharma formulation and generic medicines major illnesses like neurology, cardiovascular, antibiotics, anesthesia etc
  • Company has a contract manufacturing and quality control facility tie up with companies approved by FDA

Clientele base of the company

Company caters both domestic and international clients.

  • Company has presence in Uttar Pradesh, Tamil Nadu, Karnataka, Arunachal Pradesh, Telangana, Gujarat,
    Kerala, West Bengal, Maharashtra, Bihar and Madhya Pradesh.
  • CBC is registered vendor and supply to hospitals, Municipality and govt. supply Rajasthan & nursing homes,
    Institutes.
  • Company exports its Formulation to countries like Philippine, Bolivia, etc

Purpose of this IPO

Purpose of the issue:

  • To meet up the working capital requirements of the company
  • General corporate purposes
  • To meet up issue expenses
  • To set up distribution and warehousing facility

Chandra Bhagat Pharma Ltd IPO Issue Details

Issue Details
Issue Open 31st January 2020, Friday Issue Close 6th February 2020, Thursday
Issue Type Fixed Price IPO Issue Face Value Rs 10 Per Equity Share
Price Band Rs 51 Per Equity Shares Bid Lot & Minimum order quantity 2000 Shares
Issue Size Rs 10.2 Crore Listing at BSE SME

Chandra Bhagat Pharma Ltd IPO Timeline

Tentative IPO Timeline
Bid Opens on 31st January 2020, Friday Bid Closes on 6th January 2020, Thursday
Finalization of basis of allotment 11th February 2020, Tuesday Initiation of Refunds 12th February 2020, Wednesday
Credit of shares to demat account 13th February 2020, Thursday Listing Date 14th February 2020, Friday

Company Financials

For the year/period ended (₹ in Lakhs)
30-July-19
31-Mar-19
31-Mar-18
31-Mar-17
Total Assets 8,594.26 8,285.52 5,805.76 5,589.60
Total Revenue 3,344.50 10,671.83 9,773.41 9,028.11
Profit After Tax 24.88 62.59 103.38 66.03

Ratings & Reviews of Chandra Bhagat Pharma Ltd IPO

As per experts one could apply for IPO at their own risk

Investors are advised to conduct proper due diligence before investing in this IPO

Litigation Details

As per the information available, following is the status of litigation related to the company.

Name of Case
No of Cases
Aggregate amount involved (₹ )
Litigations by Company, Promoters and Executive Directors
Notice – Recovery of Dues 2 1,74,665
Litigations against Company, Promoters and Executive Directors
Notice – Recovery of Dues – U/S 138 of Negotiable Instruments Act,
1881
2 28,70,872
Notice – Recovery of Dues 2 49,92,458
Criminal Case U/S 138 of Negotiable Instruments Act, 1881 1 32,87,838
Under the Drugs & Cosmetics Act, 1940 3 Not Quantifiable
E-proceeding under Income Tax Act, 1961 3 85,51,896
Order against the Company by ITO- 6(2)(1), Mumbai u/s 143 (3) r.w.s.
147 of the Income Tax Act, 1961 for AY 2010-11
1 4,14,312
Income Tax Demands for AY 2007-08, 2008-09, 2009-10, 2012-13,
2014-15 and 2018-19
6 25,48,565
Demands for Tax Deducted at Source raised by Income Tax 37 21,76,980
Under Professional Tax Act, 1975 for non-filing of Return Of April, 2019 To August, 2019 1 Not Quantifiable
Income Tax Demands for AY 2008-09 against Mr. Hemant Bhagat 1 6,372

Red Herring Prospectus of Chandra Bhagat Pharma Ltd

Bidding Status

Bidding Status
Number of Times Subscribed (BSE + NSE)
As on Date & Time QIB NII RII Employee Others Total
Shares Offered / Reserved —- —- —- —- —- —-
Day 1 —- —- —- —- —- —-
Day 2 – —- —- —- —- —- —-
Day 3 – —- —- —- —- —- —-

Listing Day Information

Listing Day Trading Information
BSE NSE
Issue Price
Open
Low
High
Last Trade
Volume

IPO Lead Managers

Address of Chandra Bhagat Pharma Ltd

Chandra Bhagat Pharma Ltd
323-F Bhagat Bhuvan,
Dr. Ambedkar Road,
Matunga (East) Mumbai- 400019

Phone: +91 22 2414 6154

For more information on Latest IPOs visit, iponivesh.com